When on-line averaging is invoked, some signal amplitude excursions may need to be excluded during the averaging process. Artifact Rejection is a feature for just this purpose. When artifact rejection is enabled, the MP150 System will ignore any trials that contain signals exceeding the artifact rejection thresholds, keep track of how many trials have been rejected, and add that number of trials to the total number of trials to be acquired. This allows users to “re-try” a trial that was rejected due to the presence of artifact.
Occasionally during an acquisition, extreme levels of artifact will be present for one reason or another. Checking artifact rejection allows users to determine what signal levels constitute artifact, and have the MP150 System reject these trials.
This application note provides a procedure/test case to confirm that AcqKnowledgeArtifact Rejection is functioning properly.
The fEMG Electromyography Smart Amplifier is designed specifically for recording facial EMG signals and electrical activity from other small muscle groups. Use with AcqKnowledge™ software to analyze facial expressions and startle paradigms. BIOPAC’s new Smart Amplifiers are designed for great data. Smart Amplifiers improve performance by amplifying the physiological signal close to the subject, which allows a high-level […]
Recent psychophysiological studies feature BIOPAC’s MP Research series of Data Recorders and AcqKnowledge software. Creating Adaptive Assistants for helicopter crews based on Real-time Physiological Data In the Mercedes S-Class, biometric tools track a driver’s eyes, heart rate, and other physiological data, with one goal in mind: Making sure drivers are alert and safe on the […]
BIOPAC’s just released Introductory ECG Guide addresses fundamental to advanced concerns to optimize electrocardiography data recording and analysis. Topics include: ECG Complex; Electrical and Mechanical Sequence of a Heartbeat; Systole and Diastole; Configurations for Lead I, Lead II, Lead III, 6-lead ECG, 12-lead ECG, precordial leads; Ventricular Late Potentials (VLPs); ECG Measurement Tools; Automated Analysis Routines […]